Cameron Gray serves as Executive at Cue Biopharma, Inc., where they oversee executive responsibilities. Since joining the company, Cameron Gray has executed 8 insider transactions totaling $151.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 14, 2022 involved selling 51,562 shares valued at $165.0K.
Cameron Gray currently holds 687,049 shares of Cue Biopharma, Inc. (CUE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Cameron Gray has been a net buyer of CUE stock. They have purchased $151.5K and sold $0 worth of shares.
Cameron Gray's most recent insider trade was on Jun 14, 2022, when they sold 51,562 shares at $3.20 per share.
Get notified when new Form 4 filings are submitted
| $2.70 |
| Discretionary |
| Dec 2, 2020 | CUE | $0 | Gift | 271,000 | $N/A | Discretionary |
| Dec 2, 2020 | CUE | $0 | Gift | 162,600 | $N/A | Discretionary |
| Dec 2, 2020 | CUE | $0 | Gift | 596,200 | $N/A | Discretionary |
| Dec 2, 2020 | CUE | $0 | Gift | 162,600 | $N/A | Discretionary |
| Sep 30, 2020 | CUE | $76.5K | Purchase | 5,000 | $15.30 | Discretionary |
| Sep 29, 2020 | CUE | $75.0K | Purchase | 5,000 | $15.00 | Discretionary |